Journal rankings · indicator year 2007
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2007
Oncology journal rankings 2007
126 ranked journals · Subfield in Medicine
Oncology has 126 ranked journals in 2007. The median journal has an OJR of 0.90, below the world average of 1.00, up 0.04 on 2006; Q1 starts at OJR 1.40. The top three are CA A Cancer Journal for Clinicians, Cancer Cell, and Nature Medicine.
Ranks and citation indicators: 2007. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2004–2006, the window the 2007 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery444
- Pulmonary and Respiratory Medicine194
- Public Health, Environmental and Occupational Health163
- Cardiology and Cardiovascular Medicine162
- Oncology126
- Epidemiology108
- Infectious Diseases101
- Psychiatry and Mental health93
- Radiology, Nuclear Medicine and Imaging91
- Neurology86
- Endocrinology, Diabetes and Metabolism84
- Physiology82
Show all 42 subfields
- Orthopedics and Sports Medicine60
- Pediatrics, Perinatology and Child Health57
- Dermatology52
- Hematology51
- Ophthalmology51
- Obstetrics and Gynecology44
- Rheumatology38
- Nephrology34
- Pharmacology33
- Reproductive Medicine31
- Emergency Medicine28
- Complementary and alternative medicine26
- Geriatrics and Gerontology23
- Otorhinolaryngology18
- Rehabilitation18
- Pathology and Forensic Medicine17
- Immunology and Allergy15
- Critical Care and Intensive Care Medicine14
- Genetics10
- Anesthesiology and Pain Medicine8
- Hepatology8
- Gastroenterology6
- Urology6
- Internal Medicine4
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
126 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2006. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2004–2006, the window the 2007 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2004–2006 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2007. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 31.01Q1 | 86.45 16.31 up from 2006 | 62 | 100% | $4,330 | ||
2Cancer CellCell Press · Netherlands | 6.32Q1 | 17.94 1.02 up from 2006 | 411 | 100% | $10,400 | ||
3Nature MedicineNature Portfolio · United States | 5.34Q1 | 10.48 2.27 down from 2006 | 1,263 | 15% | $12,690 | ||
4Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 4.83Q1 | 12.28 0.95 up from 2006 | 3,072 | 9% | — | ||
5JNCI Journal of the National Cancer InstituteOxford University Press · United States | 4.41Q1 | 12.01 1.01 up from 2006 | 768 | 40% | $5,436 | ||
6Clinical Pharmacology & TherapeuticsWiley · United States | 3.12Q1 | 5.87 0.33 down from 2006 | 484 | 9% | $4,410 | ||
7The Lancet OncologyElsevier BV · United Kingdom | 3.07Q1 | 7.82 1.13 up from 2006 | 471 | 3% | $7,280 | ||
8Seminars in Cancer BiologyElsevier BV · United States | 2.85Q1 | 7.57 0.07 up from 2006 | 192 | 37% | $6,060 | ||
9JNCI MonographsOxford University Press · United Kingdom | 2.73Q1 | 4.49 0.08 up from 2006 | 94 | 50% | — | ||
10Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 2.51Q1 | 6.56 0.17 down from 2006 | 3,377 | 25% | — | ||
11The OncologistOAAlphaMed Press · United Kingdom | 2.36Q1 | 5.54 0.23 down from 2006 | 374 | 71% | $3,852 | ||
12Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 2.26Q1 | 5.23 0.22 up from 2006 | 256 | 4% | $4,190 | ||
13CancerWiley · United States | 2.18Q1 | 5.12 0.20 up from 2006 | 2,491 | 58% | $4,790 | ||
14Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 1.99Q1 | 5.13 0.33 down from 2006 | 777 | 12% | — | ||
15Journal of Mammary Gland Biology and NeoplasiaSpringer Science+Business Media · United States | 1.97Q1 | 4.31 0.20 up from 2006 | 85 | 17% | $4,090 | ||
16European Journal of CancerElsevier BV · United Kingdom | 1.96Q1 | 4.96 0.46 up from 2006 | 1,090 | 17% | $4,270 | ||
17Annals of OncologyElsevier BV · Netherlands | 1.94Q1 | 4.63 0.17 down from 2006 | 1,374 | 94% | $5,080 | ||
18British Journal of CancerSpringer Nature · United Kingdom | 1.92Q1 | 5.26 0.12 up from 2006 | 1,912 | 100% | $5,190 | ||
19Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 1.91Q1 | 5.08 0.22 up from 2006 | 1,293 | 33% | — | ||
20Cancer Causes & ControlSpringer Science+Business Media · Netherlands | 1.80Q1 | 4.24 0.53 up from 2006 | 408 | 16% | $3,890 | ||
21International Journal of CancerWiley · United States | 1.70Q1 | 4.55 0.22 up from 2006 | 2,380 | 63% | $5,030 | ||
22Psycho-OncologyWiley · United Kingdom | 1.68Q1 | 2.84 0.12 down from 2006 | 307 | 17% | $4,940 | ||
23Diseases of the Colon & RectumLippincott Williams & Wilkins · United States | 1.68Q1 | 3.42 0.05 up from 2006 | 943 | 6% | — | ||
24Current Opinion in OncologyLippincott Williams & Wilkins · United Kingdom | 1.67Q1 | 3.68 0.45 down from 2006 | 219 | 4% | — | ||
25Seminars in OncologyElsevier BV · United States | 1.63Q1 | 3.81 0.32 down from 2006 | 520 | 6% | $3,550 | ||
26Journal of ImmunotherapyLippincott Williams & Wilkins · United States | 1.60Q1 | 5.19 0.44 up from 2006 | 195 | 8% | — | ||
27Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.53Q1 | 3.91 0.51 up from 2006 | 408 | 2% | — | ||
28Cancer Treatment ReviewsElsevier BV · United Kingdom | 1.52Q1 | 4.08 0.20 up from 2006 | 207 | 7% | $4,910 | ||
29JBIC Journal of Biological Inorganic ChemistrySpringer Science+Business Media · Germany | 1.50Q1 | 3.21 0.18 down from 2006 | 329 | 24% | $3,990 | ||
30Integrative Cancer TherapiesOASAGE Publishing · United States | 1.44Q1 | 2.40 0.22 up from 2006 | 120 | 100% | $2,650 | ||
31BMC CancerOABioMed Central · United Kingdom | 1.40Q1 | 3.48 0.52 up from 2006 | 558 | 100% | $3,390 | ||
32Journal of Inorganic BiochemistryElsevier BV · United States | 1.40Q1 | 3.27 0.38 up from 2006 | 756 | 18% | $4,220 | ||
33Supportive Care in CancerSpringer Science+Business Media · Germany | 1.36Q2 | 2.37 0.12 down from 2006 | 490 | 14% | $4,690 | ||
34Cancer ControlOASAGE Publishing · United States | 1.34Q2 | 3.23 1.20 up from 2006 | 145 | 44% | $2,650 | ||
35Journal of Surgical OncologyWiley · United States | 1.29Q2 | 2.70 0.18 up from 2006 | 592 | 14% | $4,570 | ||
36Current Treatment Options in OncologySpringer Science+Business Media · United States | 1.21Q2 | 3.03 0.66 up from 2006 | 142 | 8% | $4,890 | ||
37Cancer NursingLippincott Williams & Wilkins · United States | 1.21Q2 | 2.34 0.47 up from 2006 | 185 | 2% | — | ||
38MicrocirculationWiley · United States | 1.19Q2 | 3.36 0.36 up from 2006 | 167 | 10% | $3,920 | ||
39Journal of Clinical PathologyBMJ · United Kingdom | 1.16Q2 | 2.47 0.17 down from 2006 | 993 | 69% | — | ||
40Investigational New DrugsSpringer Science+Business Media · Netherlands | 1.15Q2 | 2.91 0.23 up from 2006 | 204 | 13% | $4,690 | ||
41European Journal of EpidemiologySpringer Science+Business Media · Italy | 1.14Q2 | 2.18 0.20 up from 2006 | 417 | 23% | $3,690 | ||
42CytotherapyElsevier BV · United Kingdom | 1.13Q2 | 3.53 0.78 up from 2006 | 205 | 6% | $3,300 | ||
43Cancer InvestigationTaylor & Francis · United Kingdom | 1.12Q2 | 2.50 0.39 down from 2006 | 310 | 3% | — | ||
44Clinical & Experimental MetastasisSpringer Science+Business Media · Netherlands | 1.12Q2 | 2.93 0.54 up from 2006 | 184 | 11% | $5,090 | ||
45Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.10Q2 | 3.62 0.23 up from 2006 | 518 | 100% | $4,590 | ||
46OncologyKarger Publishers · Switzerland | 1.07Q2 | 2.82 0.14 down from 2006 | 419 | 15% | — | ||
47Journal of Cancer Research and Clinical OncologyOASpringer Science+Business Media · Germany | 1.03Q2 | 2.17 0.63 down from 2006 | 353 | 100% | $4,390 | ||
48Breast Cancer ResearchOABioMed Central · United Kingdom | 1.03Q2 | 2.70 0.46 up from 2006 | 740 | 100% | $4,190 | ||
49Oncology nursing forumOncology Nursing Society · United States | 1.03Q2 | 1.96 0.16 up from 2006 | 314 | 11% | — | ||
50Expert Review of Anticancer TherapyTaylor & Francis · United Kingdom | 1.02Q2 | 2.40 0.30 up from 2006 | 386 | 9% | — |
Subfields of Medicine, with Oncology highlighted.
- Surgery444
- Pulmonary and Respiratory Medicine194
- Public Health, Environmental and Occupational Health163
- Cardiology and Cardiovascular Medicine162
- Oncology126
- Epidemiology108
- Infectious Diseases101
- Psychiatry and Mental health93
- Radiology, Nuclear Medicine and Imaging91
- Neurology86
- Endocrinology, Diabetes and Metabolism84
- Physiology82
- Orthopedics and Sports Medicine60
- Pediatrics, Perinatology and Child Health57
- Dermatology52
- Hematology51
- Ophthalmology51
- Obstetrics and Gynecology44
- Rheumatology38
- Nephrology34
- Pharmacology33
- Reproductive Medicine31
- Emergency Medicine28
- Complementary and alternative medicine26
- Geriatrics and Gerontology23
- Otorhinolaryngology18
- Rehabilitation18
- Pathology and Forensic Medicine17
- Immunology and Allergy15
- Critical Care and Intensive Care Medicine14
- Genetics10
- Anesthesiology and Pain Medicine8
- Hepatology8
- Gastroenterology6
- Urology6
- Internal Medicine4
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2007. Corpus-wide, 72.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
32 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2004–2006, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2007. Publication window: 2004–2006. How these summaries are calculated
- Ranked journals
- 126
- Window papers (baseline)
- 62,106 +26.6% from indicator year 2004
- Median OJR
- 0.90 +11.3% from indicator year 2004
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2004–2006 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.